TXG logo

10x Genomics, Inc. (TXG) Depreciation & Amortization

Annual D&A:

$43.71M+$89.00K(+0.20%)
December 31, 2024

Summary

  • As of today, TXG annual D&A is $43.71 million, with the most recent change of +$89.00 thousand (+0.20%) on December 31, 2024.
  • During the last 3 years, TXG annual D&A has risen by +$15.45 million (+54.70%).
  • TXG annual D&A is now at all-time high.

Performance

TXG Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

Quarterly D&A:

$12.25M+$2.60M(+26.94%)
September 30, 2025

Summary

  • As of today, TXG quarterly D&A is $12.25 million, with the most recent change of +$2.60 million (+26.94%) on September 30, 2025.
  • Over the past year, TXG quarterly D&A has increased by +$1.50 million (+13.96%).
  • TXG quarterly D&A is now at all-time high.

Performance

TXG Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

TTM D&A:

$42.28M+$1.50M(+3.68%)
September 30, 2025

Summary

  • As of today, TXG TTM D&A is $42.28 million, with the most recent change of +$1.50 million (+3.68%) on September 30, 2025.
  • Over the past year, TXG TTM D&A has dropped by -$2.57 million (-5.73%).
  • TXG TTM D&A is now -9.07% below its all-time high of $46.50 million, reached on March 31, 2024.

Performance

TXG TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

TXG Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+0.2%+14.0%-5.7%
3Y3 Years+54.7%+51.0%+32.7%
5Y5 Years+518.6%+151.2%+157.0%

TXG Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+54.7%at high+51.0%-9.1%+32.7%
5Y5-Yearat high+518.6%at high+151.2%-9.1%+157.0%
All-TimeAll-Timeat high+1019.3%at high+1082.5%-9.1%+3981.1%

TXG Depreciation & Amortization History

DateAnnualQuarterlyTTM
Sep 2025
-
$12.25M(+26.9%)
$42.28M(+3.7%)
Jun 2025
-
$9.65M(-1.7%)
$40.78M(-3.0%)
Mar 2025
-
$9.81M(-7.1%)
$42.03M(-3.8%)
Dec 2024
$43.71M(+0.2%)
$10.56M(-1.7%)
$43.71M(-2.5%)
Sep 2024
-
$10.75M(-1.4%)
$44.85M(-1.5%)
Jun 2024
-
$10.90M(-5.2%)
$45.52M(-2.1%)
Mar 2024
-
$11.49M(-1.8%)
$46.50M(+6.6%)
Dec 2023
$43.62M(+32.2%)
$11.71M(+2.5%)
$43.62M(+8.0%)
Sep 2023
-
$11.42M(-3.8%)
$40.38M(+8.9%)
Jun 2023
-
$11.88M(+37.8%)
$37.08M(+10.2%)
Mar 2023
-
$8.62M(+1.7%)
$33.65M(+1.9%)
Dec 2022
$33.01M
$8.47M(+4.4%)
$33.01M(+3.6%)
Sep 2022
-
$8.12M(-3.9%)
$31.86M(+2.7%)
Jun 2022
-
$8.44M(+5.9%)
$31.02M(+4.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
$7.97M(+8.9%)
$29.76M(+5.3%)
Dec 2021
$28.25M(+48.5%)
$7.32M(+0.7%)
$28.25M(+7.2%)
Sep 2021
-
$7.28M(+1.2%)
$26.35M(+10.0%)
Jun 2021
-
$7.19M(+11.1%)
$23.95M(+7.4%)
Mar 2021
-
$6.47M(+19.4%)
$22.30M(+17.2%)
Dec 2020
$19.02M(+169.2%)
$5.42M(+11.1%)
$19.02M(+15.6%)
Sep 2020
-
$4.88M(-12.0%)
$16.45M(+20.8%)
Jun 2020
-
$5.54M(+73.7%)
$13.61M(+47.7%)
Mar 2020
-
$3.19M(+12.1%)
$9.22M(+30.5%)
Dec 2019
$7.07M(+80.9%)
$2.85M(+39.4%)
$7.07M(+67.4%)
Sep 2019
-
$2.04M(+78.4%)
$4.22M(+93.6%)
Jun 2019
-
$1.14M(+10.4%)
$2.18M(+110.4%)
Mar 2019
-
$1.04M
$1.04M
Dec 2018
$3.90M(-9.3%)
-
-
Dec 2017
$4.30M
-
-

FAQ

  • What is 10x Genomics, Inc. annual D&A?
  • What is the all-time high annual D&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual D&A year-on-year change?
  • What is 10x Genomics, Inc. quarterly D&A?
  • What is the all-time high quarterly D&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly D&A year-on-year change?
  • What is 10x Genomics, Inc. TTM D&A?
  • What is the all-time high TTM D&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM D&A year-on-year change?

What is 10x Genomics, Inc. annual D&A?

The current annual D&A of TXG is $43.71M

What is the all-time high annual D&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual D&A is $43.71M

What is 10x Genomics, Inc. annual D&A year-on-year change?

Over the past year, TXG annual D&A has changed by +$89.00K (+0.20%)

What is 10x Genomics, Inc. quarterly D&A?

The current quarterly D&A of TXG is $12.25M

What is the all-time high quarterly D&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly D&A is $12.25M

What is 10x Genomics, Inc. quarterly D&A year-on-year change?

Over the past year, TXG quarterly D&A has changed by +$1.50M (+13.96%)

What is 10x Genomics, Inc. TTM D&A?

The current TTM D&A of TXG is $42.28M

What is the all-time high TTM D&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM D&A is $46.50M

What is 10x Genomics, Inc. TTM D&A year-on-year change?

Over the past year, TXG TTM D&A has changed by -$2.57M (-5.73%)
On this page